LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in ...

That same year, Do No Harm sued Pfizer over its program for its race-based eligibility requirements for a fellowship program ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

A 'game-changer' anti-smoking pill set to be rolled out on the NHS has been linked to more than 25,000 reports of side ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...

Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend contenders. Dividend stocks have long been favored by investors for the income ...

The business contact information for 122 million people circulating since February 2024 is now confirmed to have been stolen ...

Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...

The emergence of concerns surrounding the association between Depo-Provera and severe health risks, including meningioma, ...

Thank you for standing by, and welcome to the Sonos fourth quarter 2024 conference call. All lines have been placed on mute ...